Lenient versus Strict Rate Control in Patients with Atrial Fibrillation
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Rate control is often the therapy of choice for atrial fibrillation. Guidelines recommend strict rate control, but this is not based on clinical evidence. We hypothesized that lenient rate control is not inferior to strict rate control for preventing cardiovascular morbidity and mortality in patients with permanent atrial fibrillation. METHODS: We randomly assigned 614 patients with permanent atrial fibrillation to undergo a lenient rate-control strategy (resting heart rate <110 beats per minute) or a strict rate-control strategy (resting heart rate <80 beats per minute and heart rate during moderate exercise <110 beats per minute). The primary outcome was a composite of death from cardiovascular causes, hospitalization for heart failure, and stroke, systemic embolism, bleeding, and life-threatening arrhythmic events. The duration of follow-up was at least 2 years, with a maximum of 3 years. RESULTS: The estimated cumulative incidence of the primary outcome at 3 years was 12.9% in the lenient-control group and 14.9% in the strict-control group, with an absolute difference with respect to the lenient-control group of -2.0 percentage points (90% confidence interval, -7.6 to 3.5; P<0.001 for the prespecified noninferiority margin). The frequencies of the components of the primary outcome were similar in the two groups. More patients in the lenient-control group met the heart-rate target or targets (304 [97.7%], vs. 203 [67.0%] in the strict-control group; P<0.001) with fewer total visits (75 [median, 0], vs. 684 [median, 2]; P<0.001). The frequencies of symptoms and adverse events were similar in the two groups. CONCLUSIONS: In patients with permanent atrial fibrillation, lenient rate control is as effective as strict rate control and is easier to achieve. (ClinicalTrials.gov number, NCT00392613.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There was no difference in a composite of clinical events (14.9% in the strict rate control group, 12.9% in the lenient group), 560 NYHA class, or hospitalizations.560, 561”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [560]
Citations
Cites
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Self-citationVan Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
Self-citationEffect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Hohnloser, S. H., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C., & Connolly, S. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803778 · Cited by 1,129
Self-citationAtrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic
Anter, E., Jessup, M., & Callans, D. J. (2009) · Circulation · doi:10.1161/circulationaha.108.821306 · Cited by 678
Lechat, P., Hulot, J.-S., Escolano, S., Mallet, A., Leizorovicz, A., Werhlen-Grandjean, M., Pochmalicki, G., & Dargie, H. (2001) · Circulation · doi:10.1161/01.cir.103.10.1428 · Cited by 525
Nerheim, P., Birger-Botkin, S., Piracha, L., & Olshansky, B. (2004) · Circulation · doi:10.1161/01.cir.0000135472.28234.cc · Cited by 378
Van Gelder, I. C., Crijns, H. J. G. M., Blanksma, P. K., Landsman, M. L. J., Posma, J. L., Van Den Berg, M. P., Meijler, F. L., & Lie, K. I. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90352-d · Cited by 269
Self-citationConnolly, S. J., Crijns, H. J. G. M., Torp-Pedersen, C., van Eickels, M., Gaudin, C., Page, R. L., & Hohnloser, S. H. (2009) · Circulation · doi:10.1161/circulationaha.109.875252 · Cited by 261
Self-citation
Cited by
Items 701–800 of 999
Amerena, J. V., Chen, S., Sriratanasathavorn, C., Cho, J. G., Dejia, H., Omar, R., Fat, T. H., & King, A. (2015) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s22022 · Cited by 1
Atrial fibrillation guidelines for management: what's new?
Berry, E., Padgett, H., & Holton, C. (2015) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2015.10.9.426 · Cited by 2
Fibrilación auricular y flutter auricular
Calvo, N., & García‐Bolao, I. (2013) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(13)70627-9 · Cited by 2
Svetlichnaya, J., & Klein, L. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.89 · Cited by 1
Every patient with atrial fibrillation has his (her) own optimal heart rate
Liu, X., Dong, J., Du, X., Sosnowski, M., & Ma, C. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.09.002 · Cited by 1
“However, the RACE II study published afterwards shows that the prognosis of patients taking less than 110 bpm as the target rate is not inferior to that of patients taking restrict criteria mentioned previously [7].”
ResultLópes, R. D., Becker, R. C., Newby, L. K., Peterson, E. D., Hylek, E. M., Giugliano, R. P., Granger, C. B., Mahaffey, K. W., Carvalho, A. C., Berwanger, O. B., et al. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0906-z · Cited by 1
La fibrillation atriale permanente
Davy, J., Cung, T. T., Cransac, F., Massin, F., Tapiero, A., Roubille, F., & Pasquié, J. (2011) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(11)70393-7 · Cited by 2
Current Issues in Atrial Fibrillation
Khaykin, Y., & Shamiss, Y. (2012) · ISRN Cardiology · doi:10.5402/2012/376071 · Cited by 2
“Moreover 45% of the patients in both groups still had significant AFrelated symptoms at the end of the study [62].”
BackgroundWhat Tissue Does Circumferential PV Isolation Actually Modulate?
McGarry, T. J., & Narayan, S. M. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12310 · Cited by 1
Cardiac arrhythmias and pacing
Liew, R. (2012) · Srce i krvni sudovi · doi:10.5937/siks1204287l · Cited by 1
Huang, C.-S., Chen, C.-I., Liu, Y.-T., Huang, J.-H., & Chen, Y. (2014) · Europe PMC (PubMed Central) · Cited by 1
Gillis, A. M., Verma, A., Talajic, M. R., Nattel, S., & Dorian, P. (2011) · Cited by 3
The Role of Antiarrhythmics in Atrial Fibrillation
Rhee, K. (2016) · Korean Journal of Medicine · doi:10.3904/kjm.2016.90.3.198 · Cited by 1
“이에 관한 atrial fibrillation follow-up investigation of rhythm management (AFFIRM) [5]와 rate control versus electrical cardioversion for persistent atrial fibrillation (RACE) 연구[6]를 보면 의외로 심박수조절에 비해 율동조절 의 장점이 입증되지 않았다.”
InfluentialRecent Atrial Fibrillation Guidelines – Looking at Both Sides of the Atlantic
Lévy, S. (2013) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2013.2.1.8 · Cited by 1
Vorhofflimmern: Aktuelle Empfehlungen zur Diagnostik und Behandlung
Kirchhof, P. F. (2013) · Der Internist · doi:10.1007/s00108-013-3271-2 · Cited by 2
Management des Vorhofflimmerns: Aktuelle und zukünftige Strategien
Hilbert, S., Bode, K., John, S., Kircher, S., Müssigbrodt, A., Dagres, N., & Hindricks, G. (2014) · Der Kardiologe · doi:10.1007/s12181-014-0613-9 · Cited by 2
Thinking outside the Box: Rotor Modulation in the Treatment of Atrial Fibrillation.
Sehra, R., Narayan, S. M., & Hummel, J. D. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.811 · Cited by 1
Optimizing therapy in patients with atrial fibrillation and heart failure
Mulder, B. A. (2015) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1
Tratamiento farmacológico de la fibrilación auricular. Antiarrítmicos y anticoagulantes orales
Cosín-Sales, J., & Olalla, J. J. (2016) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(16)30012-7 · Cited by 10
Estrategias para el control de la frecuencia cardíaca en pacientes con fibrilación auricular
Negrete-Salcedo, A., & Gil-Roncancio, E. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.10.017 · Cited by 1
Mareev, V. Y., & Mareev, Y. V. (2017) · Kardiologiia · doi:10.18087/cardio.2401 · Cited by 1
“/ мин [37], но с появ‑ лением данных о том, что «порог безопасности» может быть выше [38], было проведено исследование RACE II (The Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control II) [39].”
Fibrilación auricular e insuficiencia cardíaca
Tortajada, G., Caorsi, W. R., & Varela, G. (2017) · Revista Uruguaya de Cardiología · doi:10.29277/ruc/32.3.14 · Cited by 4
Who Needs Pharmacologic Therapy?
Porterfield, C. P., & Malhotra, R. (2014) · PubMed · doi:10.4022/jafib.1084 · Cited by 1
ZIMETBAUM, P. J., & Falk, R. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0101-8.00020-5 · Cited by 1
Atrial Fibrillation and Atrial Flutter
Okabe, T., Chugh, A., Pelosi, F., & Morady, F. (2020) · Springer eBooks · doi:10.1007/978-3-030-28328-5_15 · Cited by 1
KHAN, M. G. (2014) · Contemporary cardiology · doi:10.1007/978-1-61779-962-4_22 · Cited by 1
Vorhofflimmern: Atrial Fibrillation
Rosemann, A. (2022) · Praxis · doi:10.1024/1661-8157/a003916 · Cited by 1
Manejo da Fibrilação Atrial na Sala de Emergência
do Nascimento, T. A., Alves, N. M., & Lyra, M. G. (2022) · Revista Científica Hospital Santa Izabel · doi:10.35753/rchsi.v6i3.330 · Cited by 1
Antiarrhythmic drugs for atrial fibrillation in the outpatient setting
Tseng, A. S., DeSimone, C. V., & Kowlgi, G. N. (2023) · Minerva Medica · doi:10.23736/s0026-4806.23.08524-5 · Cited by 1
Risk factors and management strategies for atrial fibrillation
Durrani, D., Fatima, R., & Shaikh, M. (2023) · International Journal of Surgery Global Health · doi:10.1097/gh9.0000000000000318 · Cited by 1
Martín-Mojarro, E., Gil, V., Llorens, P., Flores-Quesada, S., Ungerer, O. J. T., Alquézar‐Arbé, A., Jacob, J., Herrero, P., Sánchez, C., & Miró, Ò. (2023) · Revista Clínica Española · doi:10.1016/j.rce.2023.08.001 · Cited by 1
Koldenhof, T., Gelder, I. C. V., van de Lande, M. E., Al-Jazairi, M. I. H., Tieleman, R. G., & Rienstra, M. (2024) · Heart · doi:10.1136/heartjnl-2024-324376 · Cited by 1
Ohlrogge, A. H., & Schnabel, R. B. (2024) · Springer eBooks · doi:10.1007/978-3-031-65952-2_22 · Cited by 1
Integrated Management of Persistent Atrial Fibrillation
Yue, X., Zhou, L., & Zhao, C. (2025) · Biomedicines · doi:10.3390/biomedicines13010091 · Cited by 3
Continuous Monitoring of Atrial Fibrillation in Heart Failure
Herweg, B., Barold, S. S., & Steinberg, J. S. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.06.002 · Cited by 1
Oral carvedilol in escalating doses in the acute treatment of atrial fibrillation
Chitrapu, R. V., Rao, P. R., & Reddy, G. V. (2014) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.142430 · Cited by 1
Pavlović, S. U., Kirćanski, B., Radovanović, N. N., Raspopović, S., Jovanovic, V., Nikčević, G., Živković, M., & Milašinović, G. (2015) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh1510551p · Cited by 1
Treatment of Cardiac Arrhythmias
Kapa, S., & Marchlinski, F. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6705-2_16 · Cited by 1
Rate Control in Atrial Fibrillation: Avoiding Morbidity.
Callahan, T. D. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.603 · Cited by 1
Jung, S., & Griffiths, L. G. (2011) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.238.10.1258 · Cited by 1
Soeiro, A. D. M., Leal, T. D. C. A. T., Soeiro, M. C. F. D. A., Junior, C. V. S., & de Oliveira, M. T. (2016) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.62.09.879 · Cited by 1
Haque, M. R., Kundu, A. K., Bhattacharjee, A., & Fattah, S. A. (2017) · IEEE Region Humanitarian Technology Conference · doi:10.1109/r10-htc.2017.8289063 · Cited by 1
Polyanskaya, Е. А., Миронова, С., & Koziolova, N. A. (2018) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2018-1-7-13 · Cited by 1
Кanorskiy, S. G., & Polishchuk, L. V. (2018) · Кубанский научный медицинский вестник · doi:10.25207/1608-6228-2018-25-2-82-87 · Cited by 1
Diagnóstico, tratamiento y seguimiento de la fibrilación auricular en atención primaria
Cubillo, Á. C. M., Herguedas, E. M., & González, L. P. (2018) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2018.01.002 · Cited by 1
Clarity and controversy around rate control in AF, the orphan child in AF therapeutics
Aguilar, M., & Nattel, S. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.11.024 · Cited by 1
Mori, K., Goto, T., Yamamoto, J., Muto, K., Kikuchi, S., Wakami, K., Fukuta, H., & Ohte, N. (2018) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.246.265 · Cited by 1
Acute management of atrial fibrillation with rapid ventricular response
Low, B., Shah, M., Nassour, V., & Fox, K. F. (2019) · British Journal of Hospital Medicine · doi:10.12968/hmed.2019.80.6.c82 · Cited by 1
Cardiovigilance in Atrial Fibrillation – Primordial to Quinary Prevention Intervention
Kishor, K., Bisht, D. S., & Kalra, S. (2019) · European Journal of Arrhythmia & Electrophysiology · doi:10.17925/ejae.2019.5.2.77 · Cited by 3
Endurance Exercise and Atrial Fibrillation
Sareban, M., Guasch, E., & Mont, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-35374-2_33 · Cited by 1
Rotors in Human Atrial Fibrillation
Narayan, S. M., Zaman, J. A. B., Vidmar, D., & Rappel, W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00045-6 · Cited by 1
Field, M. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-47870-0.00035-0 · Cited by 1
Ibrahim, I., Kuan, W. S., Yau, Y. W., Chua, M. T., Lin, Z., Cheng, L. T. W., Zheng, Q., Shi, L., Samuel, M., de Souza, N. N., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013642 · Cited by 1
Tong, H., Yu, J., Hong, K., Chen, J., Liu, H., & Su, H. (2020) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000481 · Cited by 1
A guide to the management of atrial fibrillation in Santa Claus
Mills, M. T., & Warriner, D. (2021) · The Medical Journal of Australia · doi:10.5694/mja2.51341 · Cited by 1
Johnson, K. M., & Cornia, P. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-19704-9_9 · Cited by 1
Cromie, N. A. (2013) · PubMed Central · Cited by 1
Sanip, Z., Yusof, Z., Loong, N. S., Naing, N. N., & Isa, W. Y. H. W. (2023) · Cureus · doi:10.7759/cureus.37181 · Cited by 1
“3% of AF patients in the clinic achieved the target VR of <80 bpm when electrocardiogram and the 24-hour Holter were used [14].”
BackgroundMethodIntegrated Chronic Care for Patients with Atrial Fibrillation
Hendriks, J. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20130314jh · Cited by 1
Leung, A. A. C., & Ghali, W. A. (2010) · PubMed Central
Nair, M., Patra, S., & Aror, V. (2011) · InTech eBooks · doi:10.5772/22371 · Cited by 1
¿Qué estrategia seguir y en qué pacientes?
Díaz, P. S., Tercedor, L., & López, M. Á. (2010) · Cardiocore · doi:10.1016/j.carcor.2010.05.004 · Cited by 1
PALLAS: Insights into permanent atrial fibrillation
Davy, J., Roubille, F., & Pasquié, J. (2012) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2011.12.001 · Cited by 1
“It is only recently, that data from some large registries [2,3] and a few randomized studies [4,5] have become available.”
BackgroundResultQuality of Life in Patients With Atrial Fibrilation
Camm, A. J. (2010) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(10)70271-1 · Cited by 7
“Surprisingly, in other studies it has not been possible to show that quality of life is improved by stricter (resting heart rate <80 bpm) rather than more lenient rate control (resting heart rate <110 bpm).(8) Thus, treatment strategy as such does not seem to influence quality of life.”
BackgroundRate Modulation Drugs in Atrial Fibrillation: What is the Clinical Impact?
Costea, A., & Platonov, P. G. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12590 · Cited by 1
Vegas, C. D. P. (2015) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/16280 · Cited by 1
Optimisation of Pacemaker Therapy for Cardiac Function
Gierula, J. (2017) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Atrial fibrillation and obstructive lung disease: Don’t fear the β-blocker
Loring, Z., & Piccini, J. P. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.07.023 · Cited by 1
Cardiac Involvement of Myotonic Dystrophy
Itoh, H. (2022) · リハビリテーション医学 : 日本リハビリテーション医学会誌 · doi:10.2490/jjrmc.59.161 · Cited by 1
Clinical Trials for Atrial Fibrillation—What Do We Know?
Chew, D. S., & Wilton, S. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99783-7 · Cited by 1
Hua, W., Qiao, F., & Tang, W. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133727 · Cited by 1
Atrial Fibrillation and Heart Failure: Rate Versus Rhythm Control
Eleid, M. F., Cha, Y., & Shen, W.-K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7345-9_6
Tuan, J. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Hybrid thoracoscopic epicardial and transvenous endocardial catheter ablation of atrial fibrillation
Meir, M. L. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20121130mm
Drug Therapy for Rhythm and Rate Control in Atrial Fibrillation
Soldevila, J. G., & Martínez‐Rubio, A. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5475-4_5
Liew, R. (2012) · Український кардіологічний журнал
Almanac 2013: cardiac arrhythmias and pacing.
Liew, R. (2014) · Cardiologia Croatica · doi:10.15836/ccar.2014.12
Chest pain and atrial fibrillation
Murdoch, I., Turpin, S., Johnston, B., MacLullich, A. M. J., & Losman, E. D. (2014) · doi:10.1002/9781118655641.ch5
Antithrombotic management of atrial fibrillation
Pisters, R., & Crijns, H. J. G. M. (2012) · doi:10.2217/ebo.12.118
Self-citationActive Supraventricular Arrhythmias
de Luna, A. B. (2011) · Wiley eBooks · doi:10.1002/9781444391749.ch4
Bolderman, R. W. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120420rb
Cardiomiopatía inducida por taquicardia en una mujer con flutter auricular
Luna, M. Z., Saldarriaga, C., & Fernandez, R. (2013) · Acta Médica Colombiana · doi:10.36104/amc.2013.20
Tachycardia-Induced Cardiomyopathy
Riedlbauchová, L. (2015) · InTech eBooks · doi:10.5772/60716
Frecuencia cardíaca y riesgo cardiovascular
von Wichmann, M. D. L. F., & Vinyoles, E. (2011) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2010.10.003 · Cited by 2
Update on the Management of Atrial Fibrillation: Anticoagulation and Medical Therapy
Lim, S. H., Calkins, H. G., & Sinha, S. K. (2011) · Current Cardiology Reports · doi:10.1007/s11886-011-0199-9
Advances in the Pharmacologic Management of Atrial Fibrillation
Burashnikov, A., & Antzelevitch, C. N. (2011) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2010.10.006
Coupled pacing controls rapid heart rates better than paired pacing during atrial fibrillation
Kardos, A., Ábrahám, P., Mihálcz, A., Foldesi, C., & Szili‐Törok, T. (2011) · EP Europace · doi:10.1093/europace/eur308
Réduire ou ralentir la fibrillation auriculaire : est-ce la bonne question en 2010 ?
Davy, J., Roubille, F., Cung, T. T., Cransac, F., Massin, F., & Pasquié, J. (2010) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(10)70370-0
Relation Between RR Intervals and Early Diastolic Mitral Annular Velocities in Atrial Fibrillation
Kim, E. Y., Choi, Y. H., Hyeon, C. W., Cho, J. H., Kim, K. J., Lee, W. S., Lee, K. J., Kim, S., Kim, T. H., & Kim, C. J. (2012) · Korean Circulation Journal · doi:10.4070/kcj.2012.42.9.618
Streng frekvenskontroll ved atrieflimmer er unødvendig
Tveit, A. (2010) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.10.0557
Recent Changes in Practice Guidelines for Atrial Fibrillation Management
Charneski, L., & Hollands, J. M. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1498
“This recommendation comes from one randomized controlled trial, the Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control-II (RACE-II) trial, which randomized 614 patients to either a strict (less than 80 bpm) or lenient (less than 110 bpm) heart rate goal.(10)”
MethodOlshansky, B., & Sullivan, R. M. (2010) · BMJ Evidence-Based Medicine · doi:10.1136/ebm1112
Emerging options to prevent stroke in atrial fibrillation patients
Silver, B. (2012) · Research Reports in Clinical Cardiology · doi:10.2147/rrcc.s17427
“…or less than 100 during a 6-minute walk in patients with atrial fibrillation who have an ejection fraction greater than 40% and are without symptoms 27 • Consideration of aspirin and clopidogrel in patients deemed unsuitable for anticoagulation with warfarin 12 • Consideration of dronedarone in…”
Rate Control in Atrial Fibrillation
Gelder, I. C. V., & Groenveld, H. F. (2010) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2010.07.004
Self-citationBest Clinical Trials Reported in 2010
Garner, J. B., Grayburn, P. A., & Yancy, C. W. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.02.354
Strict heart-rate control is not necessary in patients with AF
King, A. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.45
Addressing the Controversy of Rate Versus Rhythm Control in Atrial Fibrillation
Contractor, T. A., Levin, V., Desai, R. V., & Marchlinski, F. E. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.09.2701 · Cited by 1
Rate versus rhythm control in persistent atrial fibrillation
Moss, A. (2014) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2014.9.10.489
Liew, R. (2011) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2011.11.001
Metadata
- Authors
- Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., Tukkie, R., Bosker, H. A., Van Veldhuisen, D. J., & Van den Berg, M. P.
- Affiliations
- University Medical Center Groningen (NL)
- Maastricht University Medical Centre (NL)
- Deventer Ziekenhuis (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Medisch Centrum Alkmaar (NL)
- Rijnstate Hospital (NL)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-04-15
- Volume
- 362
- Issue
- 15
- Pages
- 1363-1373
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2102129403
- Cited by
- 1,033
- References
- 19
- Citations by year
- 2026: 36 · 2025: 55 · 2024: 59 · 2023: 61 · 2022: 56 · 2021: 63 · 2020: 44 · 2019: 50 · 2018: 45 · 2017: 62 · 2016: 56 · 2015: 51 · 2014: 81 · 2013: 94 · 2012: 83
- FWCI
- 68.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- atrial fibrillation, rate control, resting heart rate, non-inferiority, cardiovascular morbidity and mortality, heart failure hospitalization, stroke, hemorrhage, arrhythmic events, anticoagulation
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Anti-Arrhythmia Agents, Atrial Fibrillation, Calcium Channel Blockers, Female, Follow-Up Studies, Heart Rate, Humans, Male, Middle Aged, Confidence Intervals, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.